Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Thermo Fisher Scientific Inc. TMO
$522.83
-$6.87 (-1.31%)
На 18:00, 12 мая 2023
+24.00%
Потенциал через год
Ранг: 2
Ключевые показатели
-
Marketcap
201867081163.00000000
-
week52high
611.06
-
week52low
475.77
-
Revenue
44915000000
-
P/E TTM
35
-
Beta
0.79134900
-
EPS
15.36000000
-
Last Dividend
1.40000000
-
Next Earnings Date
26 июл 2023 г. в 12:30
Описание компании
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Credit Suisse | Neutral | 25 авг 2022 г. | |
| Barclays | Overweight | Overweight | 01 авг 2022 г. |
| SVB Leerink | Outperform | Outperform | 29 июл 2022 г. |
| Morgan Stanley | Overweight | Overweight | 29 июл 2022 г. |
| Barclays | Overweight | Overweight | 13 июл 2022 г. |
| Barclays | Overweight | Overweight | 12 сент 2022 г. |
| SVB Leerink | Outperform | Outperform | 27 окт 2022 г. |
| Morgan Stanley | Overweight | Overweight | 27 окт 2022 г. |
| Citigroup | Buy | Buy | 27 окт 2022 г. |
| Barclays | Overweight | Overweight | 27 окт 2022 г. |
| Baird | Outperform | Outperform | 01 ноя 2022 г. |
| RBC Capital | Outperform | 07 дек 2022 г. | |
| Barclays | Overweight | Overweight | 29 ноя 2022 г. |
| SVB Leerink | Outperform | Outperform | 06 янв 2023 г. |
| Wells Fargo | Underweight | Underweight | 03 янв 2023 г. |
| Deutsche Bank | Buy | 14 дек 2022 г. | |
| Morgan Stanley | Overweight | Overweight | 02 февр 2023 г. |
| Cowen & Co. | Outperform | Outperform | 02 февр 2023 г. |
| Citigroup | Buy | Buy | 02 февр 2023 г. |
| Barclays | Overweight | Overweight | 02 февр 2023 г. |
| Barclays | Overweight | Overweight | 24 янв 2023 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Покожие компании
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| SPERLING SCOTT M | A | 16550 | 75 | 31 дек 2022 г. |
| Keith R. Alexandra | A | 488 | 57 | 31 дек 2022 г. |
| Spar Debora L | D | 979 | 200 | 15 дек 2022 г. |
| Pettiti Gianluca | D | 14450 | 2000 | 14 дек 2022 г. |
| Pettiti Gianluca | D | 0 | 4200 | 13 дек 2022 г. |
| Pettiti Gianluca | D | 16450 | 4975 | 13 дек 2022 г. |
| Pettiti Gianluca | A | 21425 | 4200 | 13 дек 2022 г. |
| Pettiti Gianluca | A | 17225 | 775 | 13 дек 2022 г. |
| Williamson Stephen | D | 23183 | 468 | 17 ноя 2022 г. |
| CASPER MARC N | D | 74155 | 100 | 17 ноя 2022 г. |
Institutional Ownership
Institutional Ownership
| Holder | Shares | Change | Date Reported |
|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 11127600 | -98014 | 31 авг 2020 г. |
| Vanguard 500 Index Fund | 8115020 | -29605 | 31 авг 2020 г. |
| SPDR S&P 500 ETF | 4165530 | -19754 | 31 авг 2020 г. |
| US Bank Vanguard Institutional 500 Index Trust | 3393380 | -15628 | 31 авг 2020 г. |
| iShares Core S&P 500 ETF | 2988240 | -16252 | 31 авг 2020 г. |
| Fidelity 500 Index Fund | 3518010 | -3806 | 31 июл 2020 г. |
| Vanguard Growth Index Fund | 3113150 | -6406 | 31 июл 2020 г. |
| American Funds Growth Fund of America | 7261900 | 280214 | 30 июн 2020 г. |
| American Funds AMCAP Fund | 3542850 | -6227 | 30 июн 2020 г. |
| Vanguard Health Care Fund | 3347390 | 696194 | 30 июн 2020 г. |
Новостная лента
The 3 Most Promising Nanotechnology Stocks to Buy
InvestorPlace
05 мая 2023 г. в 15:37
Nanotechnology refers to technologies based on materials between 1 and 100 nanometers in size, which is the microscopic level. Accordingly, the production of such materials from nanotechnology stocks represent impressive upside, for those bullish on certain key industries.
This Top Fund Manager Buys Growth Stocks Without Paying Too Much
Investors Business Daily
05 мая 2023 г. в 07:00
Daniel Morris, manager of top mutual fund Manor Growth Fund (MNRGX), admits he has a conservative streak. The post This Top Fund Manager Buys Growth Stocks Without Paying Too Much appeared first on Investor's Business Daily.
Got $5,000? Buy These 2 Stalwart Stocks and Hold Them Forever
The Motley Fool
03 мая 2023 г. в 10:07
Stalwarts are companies that have stood the test of time without trouble. Thermo Fisher's recent headwinds should have little impact on its long-term outlook.
Thermo Fisher (TMO) Q1 Earnings Beat Estimates, Margins Down
Zacks Investment Research
26 апр 2023 г. в 12:11
The year-over-year growth in the Analytical Instruments and the Laboratory Products and Biopharma Services segments drove Thermo Fisher's (TMO) Q1 revenues.
Trade Deficit Comes in Lesser Than Expected
Zacks Investment Research
26 апр 2023 г. в 12:11
Trade Deficit Comes in Lesser Than Expected.